6053 - Thromboembolism: Drugs (Answered)

Luciana Berger
To ask the Secretary of State for Health, pursuant to the Answer of 7 July 2015 to Question 5418, for what reasons the report of the review of the use of the drug alteplase was not published at the start of 2015 as originally planned.

George Freeman

The original timeline for the completion of the review was extended to enable a comprehensive evaluation of relevant data, some of which became available in 2015. The Group’s conclusions and recommendations remain confidential while the review is ongoing and will be published after their consideration by the Commission on Human Medicines.